

Scores at time of recommendation (May 25, 2026)
Bakkafrost (BAKKA.OL): Five-Year Timeline, 2020–2026
The Scottish Acquisition and Investment Cycle
Bakkafrost completed its takeover of The Scottish Salmon Company in 2019–2020 and committed to a DKK 6.2bn investment programme aimed at transforming Scottish operations and scaling production through 2026. The integration unfolded against Covid disruption and, more seriously, severe biological problems that emerged in Scotland by late 2021. Those setbacks produced exceptional mortality charges around DKK 174.6m (roughly £20m), materially reducing operational EBIT and triggering an expanded freshwater treatment and vessel-capacity programme.
The Narrative Shift
Initially, the market viewed Bakkafrost as a takeover-and-turnaround case, but investor confidence was shaken by pandemic pressures and the 2021 Scottish biological losses. From 2022 onward, the dominant story changed: the company repositioned itself as an investment-led premium producer, anchored on large-smolt and RAS technology, higher controlled smolt output from Applecross, and an integrated "One Company" approach across Scotland and the Faroe Islands. Global salmon prices spiked to record levels in spring 2022 before softening amid broader macro disruption, but 2024–2025 results and management commentary reflected improving Scottish performance as the Applecross RAS and large-smolt rollout began to scale meaningfully.
Share Performance and Technical Phases
The stock reached an all-time high in October 2021 during a broad sector rally, then entered a more volatile regime. The 2022–2023 period saw large intra-year swings, notable drawdowns and range-bound trading as salmon spot prices and company-specific biological risks moved rapidly. From 2024 into 2025, the chart stabilized and partially recovered, tied to operational improvements and higher harvest volumes. By 2026, sentiment had turned more constructive as harvest volumes increased, operational EBIT remained positive and management emphasized balance-sheet resilience and dividend policy, bringing the share into its current range around 465.4.
Bakkafrost controls the entire salmon production value chain—from feed production to market distribution—a rarity among global salmon producers. This vertical integration delivers structural cost control and quality assurance that competitors simply cannot replicate, especially those without their own feed operations or access to the Faroe Islands' specific geographic advantages. The current NOK 463 price reflects recent margin compression; EBIT margins have contracted from 18.5% in 2023 to 12.5% in 2025, primarily due to startup challenges in Scotland and biological headwinds. Yet EPS estimates show meaningful recovery, jumping from 17.8 to nearly 25—the company is growing through this weakness. If you're betting on structurally rising protein demand, constrained aquaculture capacity globally, and a disciplined operator with genuine competitive moats, the setup here warrants attention.
Bakkafrost P/F (BAKKA.OL) is a vertically integrated Atlantic salmon producer with operations spanning farming, processing, and feed production across the Faroe Islands and Scotland [1][3]. It competes against larger Norwegian and international players—Mowi, SalMar, and Grieg Seafood among them—who leverage scale advantages, integrated feed operations, and established processing and export networks [23][24][28]. The business carries meaningful exposure to biological and farming risks, volatile feed and input costs, fluctuating global salmon prices, and the regulatory and environmental constraints specific to its operating jurisdictions [1][17][11].
Bakkafrost operates in a concentrated Atlantic-salmon market dominated by large, vertically integrated producers—Mowi, SalMar, Lerøy Seafood and Grieg Seafood among them. The company positions itself as a premium, fully integrated producer with operations in the Faroes and Scotland, but it remains exposed to cyclical salmon prices and the cost advantages that scale brings to larger competitors. The real vulnerabilities are more granular: biological performance can swing, feed costs inflate unpredictably, and regulatory and environmental constraints tighten in ways that compress margins faster than you'd like.
| Company | Ticker |
|---|---|
| Mowi ASA | MOWI.OL |
| SalMar ASA | SALM.OL |
| Lerøy Seafood Group ASA | LSG.OL |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | P/f Bakkafrost | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +4.87% | +0.16% | -0.58% |
| 3M | +3.21% | +3.75% | -6.49% |
| 6M | +1.26% | -4.24% | -9.18% |
| 1Y | -1.54% | -6.16% | -30.69% |
| 3Y | -33.45% | -91.09% | -119.12% |
| 5Y | -31.62% | -93.66% | -122.92% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 22.6 | 2.6 | 1.7 | 7.5 |
| 1Y ago | 74.3 | 2.6 | 1.7 | 3.0 |
| 3Y ago | 19.5 | 3.6 | 2.5 | 19.2 |
| 5Y ago | 31.0 | 6.9 | 3.4 | 128.3 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 5.06 DKK | 1.60% | 3.58% |
| 2025 | 13.37 DKK | 4.05% | |
| 2024 | 13.69 DKK | 3.20% | |
| 2023 | 15.63 DKK | 3.18% | |
| 2022 | 6.70 DKK | 1.37% | |
| 2021 | 4.96 DKK | 1.02% | |
| 2019 | 10.63 DKK | 3.20% | |
| 2018 | 13.46 DKK | 3.83% | |
| 2017 | 10.68 DKK | 4.80% | |
| 2016 | 10.37 DKK | 4.10% | |
| 2015 | 6.86 DKK | 4.39% | |
| 2014 | 4.96 DKK | 5.53% | |
| 2013 | 2.04 DKK | 2.89% | |
| 2012 | 1.02 DKK | 2.74% | |
| 2011 | 4.09 DKK | 7.84% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 7.01B | 7.33B | 7.14B | 7.13B | 5.55B |
| Operating income (EBIT) | 877.82M | 1.04B | 1.32B | 1.83B | 1.18B |
| Net income | 530.17M | 656.60M | 955.57M | 1.35B | 964.05M |
| Free cash flow | -56.49M | 1.33B | 226.07M | -33.82M | 8.87M |
| Total assets | 18.95B | 17.63B | 17.84B | 16.88B | 14.63B |
| Equity | 11.04B | 11.17B | 10.86B | 10.39B | 9.35B |
| Net debt | 3.90B | 3.00B | 3.53B | 2.66B | 2.46B |